Clinical Trials on X-Linked Emery-Dreifuss Muscular Dystrophy
Total 714 results
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, France, Netherlands, Puerto Rico, United Kingdom
-
National Institute of Neurological Disorders and...CompletedFabry DiseaseUnited States
-
National Institute of Neurological Disorders and...Completed
-
National Institute of Neurological Disorders and...CompletedHealthy | Fabry DiseaseUnited States
-
Children's Hospital of Fudan UniversityNot yet recruiting
-
Westfälische Wilhelms-Universität MünsterChiesi GmbHRecruiting
-
ISU Abxis Co., Ltd.RecruitingFabry DiseaseKorea, Republic of
-
SanofiRecruiting
-
SanofiRecruitingFabry's DiseaseUnited States
-
Bio Sidus SARecruiting
-
Hospital Clinico Universitario de SantiagoAlvaro Hermida (Co-IP); Susana Belen Bravo; Maria Teresa Cardoso; Cristobal Colon... and other collaboratorsRecruiting
-
Amicus TherapeuticsRecruiting
-
Amicus Therapeutics France SASCompletedFabry Disease | Anderson Fabry DiseaseFrance
-
University Health Network, TorontoOzmosis Research Inc.Completed
-
4D Molecular TherapeuticsActive, not recruiting
-
Bio Sidus SACompleted
-
TakedaCompleted
-
AVROBIOTerminatedFabry DiseaseUnited States, Australia, Brazil
-
National and Kapodistrian University of AthensCompletedFabry DiseaseGreece
-
Genzyme, a Sanofi CompanyCompleted
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Denmark, Belgium, United Kingdom, Norway, Italy, Czechia
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Spain, United Kingdom, Paraguay
-
Chiesi Farmaceutici S.p.A.Iqvia Pty Ltd; ProtalixCompletedFabry DiseaseUnited States, Belgium, Denmark, Italy, United Kingdom
-
University of UtahGenzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States
-
Amicus TherapeuticsCompletedFabry DiseaseUnited Kingdom, United States
-
Manchester University NHS Foundation TrustNorthern Care Alliance NHS Foundation TrustCompletedFabry DiseaseUnited Kingdom
-
Children's Hospital of Fudan UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Wuhan Union Hospital, China and other collaboratorsWithdrawn
-
ShireCompletedFabry DiseaseCanada, United States
-
ShireCompletedFabry DiseaseUnited States, United Kingdom, Australia, Czechia, Finland, Paraguay, Poland, Slovenia
-
ShireCompleted
-
ShireCompletedFabry DiseaseFinland, Sweden, Germany, Belgium, Czechia, Denmark
-
CENTOGENE GmbH RostockShire Human Genetic Therapies, Inc.CompletedFabry Disease | Cerebrovascular AccidentAustria, Croatia, France, Germany, Poland, Portugal, Georgia
-
Amicus TherapeuticsApproved for marketingPhysician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry DiseaseFabry DiseaseUnited States, Australia
-
Amicus TherapeuticsCompletedFabry DiseaseAustralia, Brazil
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States
-
Amicus TherapeuticsTerminatedFabry DiseaseUnited Kingdom, United States, Australia, Brazil, France
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, United Kingdom
-
Chiayi Christian HospitalSanofiUnknown
-
National Institute of Neurological Disorders and...CompletedFabry DiseaseUnited States
-
National Institute of Neurological Disorders and...Completed
-
Spital LinthUniversity of Zurich; National University, SingaporeUnknown
-
University Hospital, BordeauxUnknown
-
O & O Alpan LLCCompletedFabry DiseaseUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsSpain, Canada, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BUnited States